recent publications

• academic article

  • Li, Y. X., O'Dell, S., Wilson, R., Wu, X., Schmidt, S. D., Hogerkorp, C. M., Louder, M. K., Longo, N. S., Poulsen, C., Guenaga, J., Chakrabarti, B. K., Doria-Rose, N., et al. Hiv-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteins Journal of Virology  2012 86:11231-11241  DOI:10.1128/jvi.01543-12  PMID:22875963  PMCID:PMC3457177
  • Wu, X. L., Zhou, T. Q., Zhu, J., Zhang, B. S., Georgiev, I., Wang, C., Chen, X. J., Longo, N. S., Louder, M., McKee, K., O'Dell, S., Perfetto, S., et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing Science  2011 333:1593-1602  DOI:10.1126/science.1207532  PMID:21835983  PMCID:PMC3516815
  • Wu, X. L., Yang, Z. Y., Li, Y. X., Hogerkorp, C. M., Schief, W. R., Seaman, M. S., Zhou, T. Q., Schmidt, S. D., Wu, L., Xu, L., Longo, N. S., McKee, K., et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to hiv-1 Science  2010 329:856-861  DOI:10.1126/science.1187659  PMID:20616233  PMCID:PMC2965066
  • Asabe, S., Wieland, S. F., Chattopadhyay, P. K., Roederer, M., Engle, R. E., Purcell, R. H., Chisari, F. V. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection Journal of Virology  2009 83:9652-9662  DOI:10.1128/jvi.00867-09  PMID:19625407  PMCID:PMC2748002
  • Martin, J. E., Sullivan, N. J., Enama, M. E., Gordon, I. J., Roederer, M., Koup, R. A., Bailer, R. T., Chakrabarti, B. K., Bailey, M. A., Gomez, P. L., Andrews, C. A., Moodie, Z., et al. A DNA vaccine for ebola virus is safe and immunogenic in a phase i clinical trial Clinical and Vaccine Immunology  2006 13:1267-1277  DOI:10.1128/cvi.00162-06  PMID:16988008
  • Graham, B. S., Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Martin, J. E., McCluskey, M. M., Chakrabarti, B. K., Lamoreaux, L., Andrews, C. A., Gomez, P. L., et al. Phase 1 safety and immunogenicity evaluation of a multiclade hiv-1 DNA candidate vaccine Journal of Infectious Diseases  2006 194:1650-1660  DOI:10.1086/509259  PMID:17109336  PMCID:PMC2428069
  • Catanzaro, A. T., Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Gu, L., Martin, J. E., Novik, L., Chakrabarti, B. K., Butman, B. T., Gall, J. G. D., et al. Phase 1 safety and immunogenicity evaluation of a multiclade hiv-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector Journal of Infectious Diseases  2006 194:1638-1649  DOI:10.1086/509258  PMID:17109335  PMCID:PMC2428071